MOSCOW – Developers of Sputnik V, Russia's experimental COVID-19 vaccine, announced Wednesday that early, interim data from a large trial suggests the shot appears to be 92% effective.The statement, which did not include detailed information about the trial, comes just two days after a similar one from Pfizer Inc., but is based on far fewer virus cases.
Some experts suggest the data may have been rushed out in an effort to keep up with the worldwide race for a successful coronavirus vaccine.Russia touted Sputnik V, a two-shot vaccine, as the world's first to receive a government go-ahead after it was approved in early August without completing advanced testing.
Read more on clickorlando.com